Quality of life and current needs of cancer survivors enrolled in Humanitas Research Hospital's survivorship care model.

Authors

null

Elena Lorenzi

Humanitas Clinical and Research Center, Rozzano (MI), Italy

Elena Lorenzi , Lucia Morello , Laura Giordano , Elisa Agostinetto , Camille Grosso , Matteo Nicolosi , Isabella Maria Giovanna Garassino , Raffaele Cavina , Rita Mazza , Carmelo Carlo-Stella , Armando Santoro

Organizations

Humanitas Clinical and Research Center, Rozzano (MI), Italy, Humanitas Clinical and Research Center and Humanitas University, Rozzano (MI), Italy

Research Funding

Other

Background: While there are different studies investigating the quality of life (QoL) of cancer patients (pts) during active treatment, few studies report QoL of cancer survivors (CS) after at least 5 years (yrs) from achieving complete remission. We have investigated QoL and concerns about physical\psychological symptom of CS enrolled in our survivorship program from April 2015 to December 2016. Methods: We included pts > 18 yrs affected by hematologic or solid tumors after at least 5 yrs from achieving complete remission. A cross-sectional survey was carried out using validated scales: Cancer Survivors Survey of Needs subscale and a single-item measure of global QoL perception. Results: We analyzed data from 178 CS. The median age was 62 yrs (52 yrs at diagnosis), 70% were females. The most frequent histological types were breast (50%), colorectal (11%) and hematologic tumors (16%). Most pts received both chemotherapy and radiation therapy. With a median observation time of 139 months, the 10-yrs cumulative incidence of second neoplasm and cardiac adverse event was 8% and 7% respectively. 133 pts (65%) reported a good QoL (score > 3). The most frequent symptoms reported were weight changes (77%), memory\concentration deficit (65%), dental\mouth problems (61%). The most common physical\psychological symptoms were fear of relapse (83%), genetic counseling (68%), living with uncertainty (66%). A positive statistically significant association (p < 0.05) was observed between previous hormonal therapy and the following concerns (score ≥2): sleep disturbance (42% vs 35%); weight gain (31% vs 24%), osteoporosis (35% vs 18%), living with uncertainty (44% vs 38%). Female reported more fear of relapse (p 0.023) and sense of uncertainty (p 0.006) than males. 92% of pts have fully or partially adhered to the survivorship care plan. Conclusions: Most CS have a good QoL perception but we observed a high percentage of pts with a low score indicating different needs to be addressed. Pts treated with hormonal therapy are at higher risk of having both physical and psychological concerns. So far, the compliance of pts with the program was high.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Abstract Details

Meeting

2018 Cancer Survivorship Symposium

Session Type

Poster Session

Session Title

Poster Session B: Chronic Anticancer Therapy; Late- and Long-term Effects/Comorbitidities; Psychosocial Issues; Risk Assessment

Track

Care Coordination, Cost, and Education,Late- and Long-term Effects/Comorbidities,Health Promotion,Psychosocial Issues,Communication and Transitions,Risk Assessment,Chronic Anti-Cancer Therapy

Sub Track

Quality-of-Life Issues

Citation

J Clin Oncol 36, 2018 (suppl 7S; abstr 170)

DOI

10.1200/JCO.2018.36.7_suppl.170

Abstract #

170

Poster Bd #

D8

Abstract Disclosures

Similar Abstracts

Abstract

2023 ASCO Annual Meeting

National Coalition for Cancer Survivorship State of Survivorship Survey.

First Author: Shelley Fuld Nasso

Abstract

2023 ASCO Annual Meeting

Yoga vs. behavioral placebo for fatigue and quality of life among older cancer survivors.

First Author: Evelyn Arana

First Author: Michelle Payan